Kendle has implemented a new biostatistics infrastructure intended to significantly enhance the analysis and delivery of quality clinical trial data for customers. According to a company statement, “The centralized SAS-based platform provides a virtual environment allowing for simultaneous access and analysis of clinical trial data by Kendle’s global Biostatistics and Scientific Programming teams from anywhere in the world, creating significant time savings and further enhancing data...